Preclinical development
Known substances also pose preclinical challenges
The development of new substances necessitates toxicological, safety-related and pharmacological investigations. We will gladly assist you with the planning and realization of these activities.
Known substances can also entail preclinical investigations – e.g. in the case of new/modified syntheses and production processes, new target populations within the framework of indication extensions, etc.
From a neutral standpoint we determine and coordinate the necessary steps
We have acquired extensive experience with new product developments (chemical, biological, high-tech) for major international companies and start-up enterprises. Thanks to our close contacts with the authorities, we are fully informed about current regulatory requirements and their fulfilment. You can put this know-how to good use. In collaboration with your company (or on your behalf) we determine which preclinical activities are necessary for the successful completion of your project. We take care of (almost) everything.
Our services at a glance
On your behalf we perform and coordinate the following assignments:
- Analysis of your product developments
- Feasibility studies
- Development planning
- Development coordination
- Development moderation
- Milestone definition
- Liaison with the regulatory authorities
- Team meetings
